Supreme Court Criticizes High Markups on Essential Cancer Drugs, Seeks Price Regulation
The Supreme Court expressed strong concern over the excessive pricing of essential cancer drugs, highlighting cases where medicines supplied to retailers at Rs 2,700 carried an MRP of Rs 27,000. The bench described this as "broad daylight dacoity" and questioned the silence of regulatory authorities. Petitions before the court seek stricter price controls, mandatory generic prescriptions, and regulation of non-scheduled medicines. The court also noted the burden on public funds when inflated prices are reimbursed under government health schemes and scheduled further hearings.
First-hand measurement across 7 sources
We measured how 7 outlets covered this story. No outlet gave this story a measurable political slant — there is no left–right reading to report. Overall sentiment is negative (32/100). Lens Score 68/100.
Outlets measured: indiatoday, thetribune, news18, deccanherald, thetelegraph, timesnow, news18. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
Sentiment was consistent across outlets (25–48/100), indicating broadly factual reporting rather than editorialising.
Coverage timeline
news18 broke this story on 22 Sept, 01:01 pm. Other outlets followed.